Overview

Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The major goal of this project is to determine whether the use of physiologic doses of corticosteroids will decrease time to shock reversal, alters the inflammatory cascade, and alters microcirculatory flow in post-cardiac arrest patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborator:
American Heart Association
Treatments:
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate